ReviewToxics2025
Lung Deposition of Particulate Matter as a Source of Metal Exposure: A Threat to Humans and Animals.
Review in Toxics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Clinical and molecular correlates of digitally quantified anthracosis in lung tissue slides: utility of an automated quantitative workflow.The journal of pathology. Clinical research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
The deposition of particulate matter (PM) in the lungs is a health problem that primarily affects individuals working in mines and other highly polluted environments. People living in large cities also accumulate PM in their lungs throughout their lives due to the high levels of air pollution often observed in urban environments. In addition to the direct effects that the physical deposition of PM causes in the lungs, such as increased levels of inflammation and fibrosis, these pollutants can be associated with additional toxic effects, including genotoxicity and other molecular, cellular, and systemic alterations that can lead to the development of multiple diseases. This occurs because PM carries a number of toxic pollutants to the lungs, especially metals and metalloids such as arsenic, lead, cadmium, chromium, and mercury. Although the histopathological effects of occupational (pneumoconiosis) or environmental (anthracosis) deposition of PM in the human lungs are well described, little is discussed about how these morphological alterations can be a proxy for acute and chronic exposure to several toxic metals. Furthermore, the effects of PM-metal complexes on the health of animals, especially those living in urban environments, are often overlooked. In this context, this narrative review aims to discuss the impacts of lung-deposited PM-metal complexes on the health of multiple species, highlighting the broad effects caused by air pollution. Using the One Health approach, this article examines how environmental issues impact the health of both humans and animals.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.